{
 "name": "祥翊",
 "slug": "tw-6676",
 "aliases": [
  "祥翊製藥股份有限公司",
  "Sunny",
  "6676"
 ],
 "ticker": "6676",
 "industry": "生技醫療業",
 "website": "http://www.sunnypharmtech.com/",
 "summary": "祥翊（6676）是興櫃的生技醫療類股公司，2005 年成立，2022 年登錄興櫃。基本資料取自臺灣證券交易所／證券櫃檯買賣中心公開資料；重大訊息見 https://drugnews.com.tw/filings/ 。",
 "facts": [
  {
   "claim": "公司全名",
   "value": "祥翊製藥股份有限公司",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "英文簡稱",
   "value": "Sunny",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "產業類別",
   "value": "生技醫療業",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "掛牌市場",
   "value": "證券櫃檯買賣中心興櫃",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "登錄興櫃日期",
   "value": "2022-01-19",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "成立日期",
   "value": "2005-02-03",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "董事長",
   "value": "吳永連",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "總經理",
   "value": "吳永連",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "實收資本額",
   "value": 1696790000,
   "unit": "新台幣元",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "簽證會計師事務所",
   "value": "資誠聯合會計師事務所",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "公司網址",
   "value": "http://www.sunnypharmtech.com/",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "產品許可：CHLORTHALIDONE",
   "value": "FDA ANDA 209068｜美國｜2022-01-25",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://api.fda.gov/drug/drugsfda.json?search=sponsor_name%3A%22SUNNY%22&limit=100",
   "note": "as_of 為FDA資料集last_updated公開更新日2026-10-21；核准日採ORIG/AP submission_status_date。申請人SUNNY為FDA申請人縮寫；品項規格：CHLORTHALIDONE 50MG；CHLORTHALIDONE 25MG。"
  },
  {
   "claim": "產品許可：AMINOCAPROIC ACID",
   "value": "FDA ANDA 213213｜美國｜2023-12-27",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://api.fda.gov/drug/drugsfda.json?search=sponsor_name%3A%22SUNNY%22&limit=100",
   "note": "as_of 為FDA資料集last_updated公開更新日2026-10-21；核准日採ORIG/AP submission_status_date。申請人SUNNY為FDA申請人縮寫；品項規格：AMINOCAPROIC ACID 0.25GM/ML。"
  },
  {
   "claim": "產品許可：AMINOCAPROIC ACID",
   "value": "FDA ANDA 209060｜美國｜2018-11-27",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://api.fda.gov/drug/drugsfda.json?search=sponsor_name%3A%22SUNNY%22&limit=100",
   "note": "as_of 為FDA資料集last_updated公開更新日2026-10-21；核准日採ORIG/AP submission_status_date。申請人SUNNY為FDA申請人縮寫；品項規格：AMINOCAPROIC ACID 1GM；AMINOCAPROIC ACID 500MG。"
  },
  {
   "claim": "產品許可：NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS)",
   "value": "FDA ANDA 208516｜美國｜2018-05-24",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://api.fda.gov/drug/drugsfda.json?search=sponsor_name%3A%22SUNNY%22&limit=100",
   "note": "as_of 為FDA資料集last_updated公開更新日2026-10-21；核准日採ORIG/AP submission_status_date。申請人SUNNY為FDA申請人縮寫；品項規格：NITROFURANTOIN 75MG + NITROFURANTOIN, MACROCRYSTALLINE 25MG。"
  },
  {
   "claim": "產品許可：CYCLOPHOSPHAMIDE",
   "value": "FDA ANDA 215089｜美國｜2023-10-26",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://api.fda.gov/drug/drugsfda.json?search=sponsor_name%3A%22SUNNY%22&limit=100",
   "note": "as_of 為FDA資料集last_updated公開更新日2026-10-21；核准日採ORIG/AP submission_status_date。申請人SUNNY為FDA申請人縮寫；品項規格：CYCLOPHOSPHAMIDE 1GM/VIAL；CYCLOPHOSPHAMIDE 2GM/VIAL；CYCLOPHOSPHAMIDE 500MG/VIAL。"
  },
  {
   "claim": "產品許可：PHYTONADIONE",
   "value": "FDA ANDA 215090｜美國｜2026-01-09",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://api.fda.gov/drug/drugsfda.json?search=sponsor_name%3A%22SUNNY%22&limit=100",
   "note": "as_of 為FDA資料集last_updated公開更新日2026-10-21；核准日採ORIG/AP submission_status_date。申請人SUNNY為FDA申請人縮寫；品項規格：PHYTONADIONE 10MG/ML。"
  },
  {
   "claim": "產品許可：CARBOPROST TROMETHAMINE",
   "value": "FDA ANDA 213118｜美國｜2021-03-25",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://api.fda.gov/drug/drugsfda.json?search=sponsor_name%3A%22SUNNY%22&limit=100",
   "note": "as_of 為FDA資料集last_updated公開更新日2026-10-21；核准日採ORIG/AP submission_status_date。申請人SUNNY為FDA申請人縮寫；品項規格：CARBOPROST TROMETHAMINE EQ 0.25MG BASE/ML。"
  },
  {
   "claim": "管線：DZP-I（diazepam injection）",
   "value": "抗焦慮｜已取得美國FDA ANDA核准（未公告字號）｜美國",
   "unit": "",
   "as_of": "2025-01-03",
   "source": "https://mopsov.twse.com.tw/mops/web/ajax_t05st01?firstin=true&year=114&month=all&step=2&seq_no=1&spoke_time=173056&spoke_date=20250103&co_id=6676&TYPEK=rotc",
   "note": "發言日期：2025-01-03 17:30:56；主旨：公告本公司Diazepam Injection獲得美國FDA核准並取得藥證(ANDA)。未取得可核對ANDA號，故僅記已公開開發/取證狀態，不寫完整產品許可欄。"
  },
  {
   "claim": "產品安全事件：Cyclophosphamide for Injection",
   "value": "因鋼質微粒啟動三批次自願回收：C23019V1、C24015V1、V24010V1",
   "unit": "",
   "as_of": "2026-07-24",
   "source": "https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/sunny-pharmtech-inc-issues-voluntary-nationwide-recall-cyclophosphamide-injection-usp-user-level-due",
   "note": "涉及1g及2g規格之特定批次，不推定所有產品被撤銷許可，也不推定回收已結束。"
  }
 ],
 "responses": [],
 "provided_by": "public_sources",
 "verified_by": "Drugnews｜藥時事",
 "verified_at": "2026-10-22",
 "disclosure": "Drugnews 依公開來源（公司公告、公開資訊觀測站、試驗登錄、主管機關文件）整理，於 verified_at 逐條核對來源；未經公司審閱。",
 "url": "https://drugnews.com.tw/companies/tw-6676.json",
 "generated_at": "2026-10-23T11:48:56.615Z"
}